Dr. Eleanor Lederer, MD

Dr. Lederer practices at UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas.

Dr. Lederer's NPI, 1952380917, was assigned on January 10, 2006. Dr. Lederer graduated from Baylor College Of Medicine in 1978. Dr. Lederer holds Texas license F1736.

Dr. Lederer's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve), at 5939 Harry Hines Blve, Dallas, TX 75235.

Dr. Lederer's primary practice is UT of Texas Southwestern University Hospital - William P. Clements Jr. - HOPD (5939 Harry Hines Blve) in Dallas, Texas. Dr. Lederer is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Lederer to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Lederer's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lederer practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lederer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lederer is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lederer's licenses on file in 2 states: Texas and Kentucky.

Dmand AI lists parathyroid gland disorder among the conditions Dr. Lederer treats.

CMS data shows 48 Medicare services from Dr. Lederer across 2 procedure codes in 2024, all of them office visits, for 58 Medicare patients. Medicare paid $4,100 for them. Every service was in an office.

CMS counts 58 Medicare patients who saw Dr. Lederer in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. Their average risk score is 3.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lederer's median patient age at 63, with 60% women.

In 2024, Dr. Lederer wrote 38 Medicare Part D claims for 13 patients. 89% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $426 in total drug cost. In 2019, CMS named 212 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lederer for performance year 2024, reported as part of a group. Dr. Lederer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lederer as offering telehealth.

Dmand AI links 101 papers to Dr. Lederer, published from 2002 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Opossums, Kidney and Cell Line. Dr. Lederer has published most often in Am J Physiol Renal Physiol. Dr. Lederer's most frequent co-authors are Wadi N. Suki, MD, Luan Dinh Truong, MD and Pedro A. Jose, MD.

Dmand AI links Dr. Lederer to 1 clinical trial. Conditions studied include Suicide and Self-Injurious Behavior.

CMS Open Payments shows 6 general payments to Dr. Lederer from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Mallinckrodt Hospital Products Inc. paid the most, $100.

Dmand AI lists 2 awards for Dr. Lederer, most recently Regional Top Doctor in 2014.

Dr. Lederer graduated from Baylor College Of Medicine in 1978. Dr. Lederer is a member of ASN.

Dr. Lederer is in network with 23 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.